KiOmedine-based Dermal Filler
Skin Aging
Pre-clinicalActive
Key Facts
About KiOmed Pharma
KiOmed Pharma is a private, Belgium-based biotechnology company capitalizing on over a decade of research into its exclusive KiOmedine® CM-chitosan platform. Derived from the white button mushroom, this pharma-grade, bioresorbable biopolymer forms the core of its pipeline targeting osteoarthritis (via a fluid implant), dermal fillers for skin aging, and formulations for ophthalmology. The company is in the commercial stage for its osteoarthritis product, KiOmedine vs one, and operates with an ISO 13485-certified manufacturing process, positioning it as a developer of differentiated medical devices in large, underserved markets.
View full company profile